Early-onset gastrointestinal cancers are rising at alarming rates in adults under 50, yet most remain outside screening protocols—leaving vague symptoms overlooked and diagnoses delayed. Experts warn that lifestyle risks like obesity, diet, and inactivity combine with barriers such as insurance and access to fuel this trend. Emerging tools—from liquid biopsies to microRNA assays—hint at earlier detection, but they’re not ready for routine use. The unsettling question: how many lives are being lost simply because we’re looking too late?
Keep Reading
Add A Comment